Risk Management (RMP & REMS)

Risk-management planning translates a product's safety profile into concrete measures that protect patients — and increasingly, regulators expect proof that those measures actually work. PharmExpert develops and maintains EU RMPs and US REMS, defining safety concerns, pharmacovigilance activities and risk-minimization measures, and evaluating their effectiveness.

We build the RMP from a clear safety specification — the important identified and potential risks and missing information — and design proportionate pharmacovigilance activities and risk-minimization measures, both routine and additional, to address them. The plan is authored to the required regulatory format and tailored to each product's real risk profile.

Risk-minimization effectiveness evaluation is a growing expectation, and we design and support it so you can demonstrate, with evidence, whether additional measures are achieving their objectives — rather than assuming they are.

Because a product's safety profile evolves, we keep the RMP current through the lifecycle, aligned to new signals, aggregate reports and labelling changes. The result is a living risk-management plan that satisfies regulators and genuinely supports safe use.